nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—Epirubicin—testicular cancer	0.423	0.547	CbGbCtD
Fluticasone Propionate—CYP3A7—Ifosfamide—testicular cancer	0.0924	0.119	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0924	0.119	CbGbCtD
Fluticasone Propionate—CYP3A5—Ifosfamide—testicular cancer	0.0693	0.0896	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—testicular cancer	0.0331	0.0428	CbGbCtD
Fluticasone Propionate—CYP3A4—Ifosfamide—testicular cancer	0.027	0.035	CbGbCtD
Fluticasone Propionate—PGR—corpus luteum—testicular cancer	0.0255	0.495	CbGeAlD
Fluticasone Propionate—CYP3A4—Vinblastine—testicular cancer	0.0143	0.0185	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—testicular cancer	0.0129	0.0167	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—testicular cancer	0.00881	0.0114	CbGbCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—testicular cancer	0.00503	1	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—seminal vesicle—testicular cancer	0.00335	0.0651	CbGeAlD
Fluticasone Propionate—NR3C2—seminal vesicle—testicular cancer	0.00272	0.0529	CbGeAlD
Fluticasone Propionate—PLA2G4A—female gonad—testicular cancer	0.00197	0.0382	CbGeAlD
Fluticasone Propionate—PLA2G4A—testis—testicular cancer	0.00174	0.0339	CbGeAlD
Fluticasone Propionate—NR3C2—female gonad—testicular cancer	0.0016	0.0311	CbGeAlD
Fluticasone Propionate—NR3C1—embryo—testicular cancer	0.00155	0.0302	CbGeAlD
Fluticasone Propionate—PGR—female gonad—testicular cancer	0.00149	0.0289	CbGeAlD
Fluticasone Propionate—NR3C1—seminal vesicle—testicular cancer	0.00146	0.0284	CbGeAlD
Fluticasone Propionate—NR3C2—testis—testicular cancer	0.00142	0.0276	CbGeAlD
Fluticasone Propionate—PGR—testis—testicular cancer	0.00132	0.0256	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—testicular cancer	0.00126	0.0246	CbGeAlD
Fluticasone Propionate—NR3C1—gonad—testicular cancer	0.00106	0.0205	CbGeAlD
Fluticasone Propionate—NR3C2—lymph node—testicular cancer	0.00103	0.02	CbGeAlD
Fluticasone Propionate—PGR—lymph node—testicular cancer	0.000956	0.0186	CbGeAlD
Fluticasone Propionate—CYP3A5—female gonad—testicular cancer	0.000864	0.0168	CbGeAlD
Fluticasone Propionate—NR3C1—female gonad—testicular cancer	0.000858	0.0167	CbGeAlD
Fluticasone Propionate—NR3C1—testis—testicular cancer	0.000761	0.0148	CbGeAlD
Fluticasone Propionate—NR3C1—lymph node—testicular cancer	0.000551	0.0107	CbGeAlD
Fluticasone Propionate—Feeling abnormal—Dactinomycin—testicular cancer	0.00031	0.00182	CcSEcCtD
Fluticasone Propionate—Nausea—Chlorambucil—testicular cancer	0.00031	0.00182	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Etoposide—testicular cancer	0.00031	0.00182	CcSEcCtD
Fluticasone Propionate—Anxiety—Cisplatin—testicular cancer	0.000309	0.00182	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000308	0.00181	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000308	0.00181	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Ifosfamide—testicular cancer	0.000307	0.00181	CcSEcCtD
Fluticasone Propionate—Discomfort—Cisplatin—testicular cancer	0.000306	0.0018	CcSEcCtD
Fluticasone Propionate—Vomiting—Vinblastine—testicular cancer	0.000304	0.00179	CcSEcCtD
Fluticasone Propionate—Malaise—Etoposide—testicular cancer	0.000301	0.00177	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—testicular cancer	0.000301	0.00177	CcSEcCtD
Fluticasone Propionate—Face oedema—Epirubicin—testicular cancer	0.0003	0.00176	CcSEcCtD
Fluticasone Propionate—Headache—Vinblastine—testicular cancer	0.000299	0.00176	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dactinomycin—testicular cancer	0.000297	0.00175	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dactinomycin—testicular cancer	0.000297	0.00175	CcSEcCtD
Fluticasone Propionate—Oedema—Cisplatin—testicular cancer	0.000297	0.00175	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Cisplatin—testicular cancer	0.000297	0.00175	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Bleomycin—testicular cancer	0.000297	0.00175	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000297	0.00175	CcSEcCtD
Fluticasone Propionate—Infection—Cisplatin—testicular cancer	0.000295	0.00174	CcSEcCtD
Fluticasone Propionate—Pain—Ifosfamide—testicular cancer	0.000295	0.00173	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Cisplatin—testicular cancer	0.000291	0.00171	CcSEcCtD
Fluticasone Propionate—Cough—Etoposide—testicular cancer	0.000291	0.00171	CcSEcCtD
Fluticasone Propionate—Tachycardia—Cisplatin—testicular cancer	0.00029	0.00171	CcSEcCtD
Fluticasone Propionate—Skin disorder—Cisplatin—testicular cancer	0.000289	0.0017	CcSEcCtD
Fluticasone Propionate—Hypertension—Etoposide—testicular cancer	0.000288	0.00169	CcSEcCtD
Fluticasone Propionate—Asthma—Methotrexate—testicular cancer	0.000287	0.00169	CcSEcCtD
Fluticasone Propionate—Pruritus—Bleomycin—testicular cancer	0.000285	0.00168	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Ifosfamide—testicular cancer	0.000284	0.00167	CcSEcCtD
Fluticasone Propionate—Chest pain—Etoposide—testicular cancer	0.000284	0.00167	CcSEcCtD
Fluticasone Propionate—Nausea—Vinblastine—testicular cancer	0.000284	0.00167	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000282	0.00166	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000282	0.00166	CcSEcCtD
Fluticasone Propionate—Discomfort—Etoposide—testicular cancer	0.000281	0.00165	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Epirubicin—testicular cancer	0.000278	0.00163	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—testicular cancer	0.000277	0.00163	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dactinomycin—testicular cancer	0.000277	0.00163	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—testicular cancer	0.000275	0.00162	CcSEcCtD
Fluticasone Propionate—Urticaria—Ifosfamide—testicular cancer	0.000274	0.00161	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Ifosfamide—testicular cancer	0.000273	0.0016	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Ifosfamide—testicular cancer	0.000273	0.0016	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Etoposide—testicular cancer	0.000272	0.0016	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000271	0.00159	CcSEcCtD
Fluticasone Propionate—Infection—Etoposide—testicular cancer	0.000271	0.00159	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Epirubicin—testicular cancer	0.00027	0.00159	CcSEcCtD
Fluticasone Propionate—Asthma—Epirubicin—testicular cancer	0.000268	0.00158	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000267	0.00157	CcSEcCtD
Fluticasone Propionate—Tachycardia—Etoposide—testicular cancer	0.000266	0.00156	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Cisplatin—testicular cancer	0.000265	0.00156	CcSEcCtD
Fluticasone Propionate—Skin disorder—Etoposide—testicular cancer	0.000264	0.00156	CcSEcCtD
Fluticasone Propionate—Bronchitis—Epirubicin—testicular cancer	0.000258	0.00152	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dactinomycin—testicular cancer	0.000257	0.00151	CcSEcCtD
Fluticasone Propionate—Pneumonia—Methotrexate—testicular cancer	0.000257	0.00151	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—testicular cancer	0.000257	0.00151	CcSEcCtD
Fluticasone Propionate—Vomiting—Bleomycin—testicular cancer	0.000256	0.00151	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Methotrexate—testicular cancer	0.000256	0.0015	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—testicular cancer	0.000256	0.0015	CcSEcCtD
Fluticasone Propionate—Rash—Bleomycin—testicular cancer	0.000254	0.0015	CcSEcCtD
Fluticasone Propionate—Pain—Cisplatin—testicular cancer	0.000254	0.00149	CcSEcCtD
Fluticasone Propionate—Dermatitis—Bleomycin—testicular cancer	0.000254	0.00149	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Ifosfamide—testicular cancer	0.000254	0.00149	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—testicular cancer	0.00025	0.00147	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000249	0.00147	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Methotrexate—testicular cancer	0.000249	0.00146	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—testicular cancer	0.000248	0.00146	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Cisplatin—testicular cancer	0.000245	0.00144	CcSEcCtD
Fluticasone Propionate—Pruritus—Ifosfamide—testicular cancer	0.000244	0.00143	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Etoposide—testicular cancer	0.000243	0.00143	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Epirubicin—testicular cancer	0.000242	0.00142	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—testicular cancer	0.000241	0.00142	CcSEcCtD
Fluticasone Propionate—Pneumonia—Epirubicin—testicular cancer	0.000241	0.00142	CcSEcCtD
Fluticasone Propionate—Nausea—Bleomycin—testicular cancer	0.00024	0.00141	CcSEcCtD
Fluticasone Propionate—Infestation—Epirubicin—testicular cancer	0.000239	0.00141	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Epirubicin—testicular cancer	0.000239	0.00141	CcSEcCtD
Fluticasone Propionate—Vomiting—Dactinomycin—testicular cancer	0.000239	0.00141	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—testicular cancer	0.000239	0.0014	CcSEcCtD
Fluticasone Propionate—Rash—Dactinomycin—testicular cancer	0.000237	0.0014	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Ifosfamide—testicular cancer	0.000236	0.00139	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Cisplatin—testicular cancer	0.000235	0.00138	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—testicular cancer	0.000233	0.00137	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—testicular cancer	0.000233	0.00137	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000231	0.00136	CcSEcCtD
Fluticasone Propionate—Dizziness—Ifosfamide—testicular cancer	0.000228	0.00134	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—testicular cancer	0.000228	0.00134	CcSEcCtD
Fluticasone Propionate—Epistaxis—Epirubicin—testicular cancer	0.000226	0.00133	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—testicular cancer	0.000225	0.00132	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—testicular cancer	0.000224	0.00132	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—testicular cancer	0.000224	0.00132	CcSEcCtD
Fluticasone Propionate—Nausea—Dactinomycin—testicular cancer	0.000223	0.00131	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—testicular cancer	0.000223	0.00131	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—testicular cancer	0.000223	0.00131	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—testicular cancer	0.000221	0.0013	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—testicular cancer	0.000221	0.0013	CcSEcCtD
Fluticasone Propionate—Vomiting—Ifosfamide—testicular cancer	0.000219	0.00129	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Cisplatin—testicular cancer	0.000219	0.00129	CcSEcCtD
Fluticasone Propionate—Rash—Ifosfamide—testicular cancer	0.000217	0.00128	CcSEcCtD
Fluticasone Propionate—Dermatitis—Ifosfamide—testicular cancer	0.000217	0.00128	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—testicular cancer	0.000216	0.00127	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—testicular cancer	0.000215	0.00127	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—testicular cancer	0.000215	0.00127	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—testicular cancer	0.000215	0.00127	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—testicular cancer	0.000215	0.00126	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—testicular cancer	0.000214	0.00126	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—testicular cancer	0.000213	0.00125	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—testicular cancer	0.000213	0.00125	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—testicular cancer	0.000211	0.00124	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—testicular cancer	0.000209	0.00123	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—testicular cancer	0.000208	0.00122	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—testicular cancer	0.000207	0.00122	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—testicular cancer	0.000207	0.00122	CcSEcCtD
Fluticasone Propionate—Nausea—Ifosfamide—testicular cancer	0.000205	0.0012	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Cisplatin—testicular cancer	0.000203	0.0012	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methotrexate—testicular cancer	0.000201	0.00118	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—testicular cancer	0.000201	0.00118	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—testicular cancer	0.000201	0.00118	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—testicular cancer	0.0002	0.00118	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—testicular cancer	0.0002	0.00118	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—testicular cancer	0.000199	0.00117	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—testicular cancer	0.000198	0.00116	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—testicular cancer	0.000197	0.00116	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000195	0.00115	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—testicular cancer	0.000194	0.00114	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—testicular cancer	0.000194	0.00114	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—testicular cancer	0.000193	0.00113	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—testicular cancer	0.000192	0.00113	CcSEcCtD
Fluticasone Propionate—Vomiting—Cisplatin—testicular cancer	0.000189	0.00111	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—testicular cancer	0.000188	0.00111	CcSEcCtD
Fluticasone Propionate—Mental disorder—Epirubicin—testicular cancer	0.000188	0.00111	CcSEcCtD
Fluticasone Propionate—Rash—Cisplatin—testicular cancer	0.000187	0.0011	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cisplatin—testicular cancer	0.000187	0.0011	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—testicular cancer	0.000187	0.0011	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—testicular cancer	0.000187	0.0011	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etoposide—testicular cancer	0.000186	0.0011	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—testicular cancer	0.000186	0.00109	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—testicular cancer	0.000185	0.00109	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—testicular cancer	0.000184	0.00109	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—testicular cancer	0.00018	0.00106	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—testicular cancer	0.00018	0.00106	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—testicular cancer	0.00018	0.00106	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—testicular cancer	0.00018	0.00106	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000179	0.00105	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—testicular cancer	0.000178	0.00104	CcSEcCtD
Fluticasone Propionate—Nausea—Cisplatin—testicular cancer	0.000177	0.00104	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—testicular cancer	0.000176	0.00104	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—testicular cancer	0.000174	0.00103	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—testicular cancer	0.000174	0.00102	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—testicular cancer	0.000174	0.00102	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—testicular cancer	0.000173	0.00102	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—testicular cancer	0.000173	0.00102	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—testicular cancer	0.000173	0.00102	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—testicular cancer	0.000172	0.00101	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—testicular cancer	0.000172	0.00101	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—testicular cancer	0.000172	0.00101	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—testicular cancer	0.000171	0.001	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—testicular cancer	0.00017	0.001	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—testicular cancer	0.00017	0.001	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000169	0.000994	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—testicular cancer	0.000169	0.000992	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—testicular cancer	0.000168	0.000989	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—testicular cancer	0.000166	0.000978	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—testicular cancer	0.000165	0.000972	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—testicular cancer	0.000163	0.00096	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—testicular cancer	0.000163	0.000959	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—testicular cancer	0.000163	0.000959	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—testicular cancer	0.000162	0.000953	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—testicular cancer	0.000162	0.000951	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—testicular cancer	0.000161	0.00095	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000161	0.000944	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—testicular cancer	0.00016	0.000941	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—testicular cancer	0.000159	0.000936	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—testicular cancer	0.000159	0.000936	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—testicular cancer	0.000159	0.000935	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—testicular cancer	0.000159	0.000933	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—testicular cancer	0.000158	0.000932	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000158	0.00093	CcSEcCtD
Fluticasone Propionate—Discomfort—Epirubicin—testicular cancer	0.000157	0.000925	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—testicular cancer	0.000156	0.000918	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—testicular cancer	0.000156	0.000916	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—testicular cancer	0.000153	0.000899	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—testicular cancer	0.000153	0.000898	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—testicular cancer	0.000153	0.000898	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—testicular cancer	0.000152	0.000892	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—testicular cancer	0.000151	0.000888	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—testicular cancer	0.00015	0.00088	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—testicular cancer	0.000149	0.000879	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—testicular cancer	0.000149	0.000876	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000149	0.000874	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—testicular cancer	0.000148	0.000872	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—testicular cancer	0.000147	0.000866	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—testicular cancer	0.000147	0.000866	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—testicular cancer	0.000147	0.000863	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000146	0.00086	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—testicular cancer	0.000146	0.000856	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—testicular cancer	0.000145	0.000855	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—testicular cancer	0.000144	0.000847	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000141	0.000831	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—testicular cancer	0.000141	0.000831	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—testicular cancer	0.00014	0.000825	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—testicular cancer	0.000139	0.00082	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000139	0.000818	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—testicular cancer	0.000139	0.000815	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—testicular cancer	0.000138	0.000811	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—testicular cancer	0.000137	0.000807	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—testicular cancer	0.000136	0.0008	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—testicular cancer	0.000134	0.00079	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000133	0.000784	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—testicular cancer	0.000131	0.000768	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—testicular cancer	0.00013	0.000762	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—testicular cancer	0.000129	0.000758	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—testicular cancer	0.000129	0.000758	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000129	0.000757	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—testicular cancer	0.000126	0.000741	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—testicular cancer	0.000126	0.00074	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000125	0.000734	CcSEcCtD
Fluticasone Propionate—Urticaria—Epirubicin—testicular cancer	0.000121	0.000713	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—testicular cancer	0.000121	0.00071	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—testicular cancer	0.000121	0.00071	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—testicular cancer	0.000121	0.00071	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methotrexate—testicular cancer	0.00012	0.000707	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—testicular cancer	0.000116	0.000684	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000115	0.000679	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—testicular cancer	0.000115	0.000679	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Epirubicin—testicular cancer	0.000112	0.000661	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—testicular cancer	0.000112	0.00066	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—testicular cancer	0.000112	0.000657	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—testicular cancer	0.000112	0.000657	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—testicular cancer	0.000112	0.000656	CcSEcCtD
Fluticasone Propionate—Pruritus—Epirubicin—testicular cancer	0.000108	0.000635	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—testicular cancer	0.000108	0.000634	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Epirubicin—testicular cancer	0.000104	0.000614	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—testicular cancer	0.000104	0.000612	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—testicular cancer	0.000104	0.00061	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—testicular cancer	0.000103	0.000605	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—testicular cancer	0.000103	0.000604	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—testicular cancer	0.000102	0.000601	CcSEcCtD
Fluticasone Propionate—Dizziness—Epirubicin—testicular cancer	0.000101	0.000594	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—testicular cancer	9.99e-05	0.000588	CcSEcCtD
Fluticasone Propionate—Vomiting—Epirubicin—testicular cancer	9.71e-05	0.000571	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—testicular cancer	9.69e-05	0.00057	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—testicular cancer	9.66e-05	0.000568	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—testicular cancer	9.62e-05	0.000566	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—testicular cancer	9.62e-05	0.000565	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—testicular cancer	9.56e-05	0.000562	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—testicular cancer	9.34e-05	0.000549	CcSEcCtD
Fluticasone Propionate—Nausea—Epirubicin—testicular cancer	9.07e-05	0.000533	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—testicular cancer	8.98e-05	0.000528	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—testicular cancer	8.91e-05	0.000524	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—testicular cancer	8.9e-05	0.000523	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—testicular cancer	8.85e-05	0.00052	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—testicular cancer	8.39e-05	0.000493	CcSEcCtD
